making muscle wasting history

New developments in the treatment of Duchenne Muscular Dystrophy from Santhera Pharmaceuticals

• Last Edited: 5 May 2009
• Permanent link

Phase III Clinical trial planned for SNT-MC17/idebenone (brand name Catena®) treatment In Duchenne Muscular Dystrophy progressive muscle weakness in patients results in respiratory and cardiac ill...

Tags: Santhera, idebenone, Catena, antioxidant, DELPHI.

Flavocoxid

• Last Edited: 4 Nov 2009
• Permanent link

A mixed flavonoid extract with anti-inflammatory, antioxidant and NF-kappaB inhibiting properties which has been shown to have beneficial effects in mdx mice in comparison with methylprednisolone,...

Tags: flavocoxid, antioxidant, antiinflammatory.

Antioxidant Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species.

• Last Edited: 13 Oct 2010
• Permanent link

Background: Duchenne muscular dystrophy is a severe X-linked congenital disorder characterized by lethal muscle wasting caused by the absence of the structural protein dystrophin. Objective: Becau...

Tags: Green tea, muscular dystrophy, reactive oxygen species, antioxidant, prevention, muscle necrosis, mdx mice, dystrophin, Xlinked congenital disease.